PATENT CLAIM ANALYSIS

Application Number: 16143748
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-05
Patent Classification: ["424", "001890"]

Abstract:
The present disclosure is directed, in part, to compounds and methods for imaging myocardial perfusion, comprising administering to a patient a contrast agent which comprises a compound that binds MC-1, and an imaging moiety, and scanning the patient using diagnostic imaging.

Claim (Index 30):
The contrast agent of  claim 27  wherein the radioisotope for nuclear medicine imaging is  11 C,  13 N,  18 F,  123 I,  125 I,  99m Tc,  95 Tc,  111 In,  62 Cu,  64 Cu,  67 Ga, or  68 Ga.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.34286
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13529756', '15153502', '14845320', '12014161', '15629068']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8072171544944265
- 35 USC 102 Novelty (BERT): 0.5886026008391163
- Combined Prediction Score: 0.7853556991288956
- Mean Citation Score: 365.333556
- Max Citation Score: 434.32803
- Similarity Product: 412.2852537105346

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test